drugset

drugset / Trial / NCT00634946

SI-6603 Versus Placebo in Patients With Lumbar Disc Herniation

NCT00634946 ↗

Phase 2/3 Completed 195 enrolled Seikagaku Corporation

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine whether SI-6603 is effective in the treatment of lumbar disc herniation.

Timeline

Start: 2008-01
Primary completion: 2009-11
Completion: 2010-08

Publications

Matsuyama Y, Chiba K, Iwata H, Seo T, Toyama Y. A multicenter, randomized, double-blind, dose-finding study of condoliase in patients with lumbar disc herniation. J Neurosurg Spine. 2018 May;28(5):499-511. doi: 10.3171/2017.7.SPINE161327. Epub 2018 Feb 9.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Condoliase	Protein / enzyme biologic	1.25 unknown	Other

Indications